Background and methods:A nano calcium-deficient hydroxyapatite (n-CDHA)-multi(amino acid) copolymer (MAC) composite bone substitute biomaterial was prepared using an in situ polymerization method. The composition, structure, and compressive strength of the composite was characterized, and the in vitro degradability in phosphate-buffered solution and preliminary cell responses to the composite were investigated. Results: The composite comprised n-CDHA and an amide linkage copolymer. The compressive strength of the composite was in the range of 88-129 MPa, varying with the amount of n-CDHA in the MAC (ranging from 10 wt% to 50 wt%). Weight loss from the composite increased (from 32.2 wt% to 44.3 wt%) with increasing n-CDHA content (from 10 wt% to 40 wt%) in the MAC after the composite was soaked in phosphate-buffered solution for 12 weeks. The pH of the soaking medium varied from 6.9 to 7.5. MG-63 cells with an osteogenic phenotype were well adhered and spread on the composite surface. Viability and differentiation increased with time, indicating that the composite had no negative effects on MG-63 cells. Conclusion:The n-CDHA-MAC composite had good cytocompatibility and has potential to be used as a bone substitute.

Poly(amino acid)/nano hydroxyapatite (PAA/n-HA) bioactive composite was prepared by in situ melting polymerization. The composition, structure and morphology as well as glass transition temperature (T g ), dynamic mechanical properties of the PAA/n-HA composite were characterized by infrared spectrometer, X-ray diffractometer, X-ray photoelectron spectroscopy, scanning electron microscope, differential scanning calorimeter, and dynamic mechanical analyzer. The results indicated that the n-HA particles were uniformly distributed into PAA matrix and some interactions were found at the interface between PAA and n-HA, and the crystallinity of PAA in the composite decreased with the increase of n-HA content. The T g and storage modulus of the composite increased with increasing n-HA content, demonstrating that the n-HA content had obvious effects on the crystallization kinetic parameters and thermo properties of the PAA/n-HA composite. In addition, the n-HA amount had evident effects on the degradation of the PAA/n-HA composite in phosphate buffered saline (PBS), and the weight loss ratio of the composite decreased with the increase with n-HA content. The pH value of the medium was stable around 7.40 after the composite immersion into PBS for 8 weeks.

No abstract

Mesoporous calcium–silicon xerogels with a pore size of 15 nm (MCS-15) and pore volume of 1.43 cm 3 /g were synthesized by using 1,3,5-mesitylene (TMB) as the pore-expanding agent. The MCS-15 exhibited good degradability with the weight loss of 50 wt% after soaking in Tris-HCl solution for 56 days, which was higher than the 30 wt% loss shown by mesoporous calcium–silicon xerogels with a pore size of 4 nm (MCS-4). The pore size and pore volume of MCS-15 had significant influences on load and release of recombinant human bone morphogenetic protein-2 (rhBMP-2). The MCS-15 had a higher capacity to encapsulate a large amount of rhBMP-2; it could adsorb 45 mg/g of rhBMP-2 in phosphate-buffered saline after 24 hours, which was more than twice that with MCS-4 (20 mg/g). Moreover, the MCS-15 system exhibited sustained release of rhBMP-2 as compared with MCS-4 system (showing a burst release). The MCS-15/rhBMP-2 system could promote the proliferation and differentiation of human mesenchymal stem cells, showing good cytocompatibility and bioactivity. The results indicated that MCS-15, with larger mesopore size and higher pore volume, might be a promising carrier for loading and sustained release of rhBMP-2, which could be used as bone repair material with built-in osteoinduction function in bone reconstruction.